EFPIA Japan Chief Raps Huge Seller Re-Pricing, Says April Reform Will Chill the Market

EFPIA Japan Chairman Carsten Brunn A special re-pricing rule for drugs logging “huge” sales, to be rolled out in April, came “out of nowhere” without a substantive dialogue with the industry, and this, together with other anti-innovation policies, will tip...read more